Deals of the day-Mergers and acquisitions

LXi REIT

22/09/2022 11:05

Sept 22 (Reuters) - The following bids, mergers,
acquisitions, and disposals were reported by 0930 GMT on
Thursday:
    ** British drugmaker GSK  GSK.L  said it would take a stake
in Spero Therapeutics  SPRO.O  as part of a licensing agreement
for the U.S.-based drug developer's experimental antibiotic for
complicated urinary tract infections (cUTI).  urn:newsml:reuters.com:*:nL4N30T1H3
    ** British supermarket group Sainsbury's  SBRY.L  has
exchanged contracts with LXi REIT  LXIL.L  on a deal to sell 18
stores in southern England for 500 million pounds ($562 million)
to the property investor and then lease them back.  urn:newsml:reuters.com:*:nL8N30T0XJ
    ** Spanish bank Sabadell  SABE.MC  has received indicative
bids from France's Worldline  WLN.PA , Italy's Nexi  NEXII.MI ,
and U.S. firm Fiserv  FISV.O  for its payments arm, with a deal
valued at upto 400 million euros ($393.64 million), three
sources said.  urn:newsml:reuters.com:*:nL1N30S31I
    ** Ball Corp  BALL.N  said on Wednesday that it has
completed the sale of its beverage packaging business in Russia
to Arnest Group for $530 million.  urn:newsml:reuters.com:*:nL4N30S3DD
 (Compiled by Rajarshi Roy and Khushi Mandowara in Bengaluru)
 ((Rajarshi.Roy@thomsonreuters.com;))